Company
Modus Therapeutics Holding AB
Headquarters: Stockholm, Sweden
Employees: 2
Modus Therapeutics Holding AB Categories
Sweden Healthcare BiotechnologySweden Healthcare Sweden Biotechnology
Top Competitors by Market Capitalization
Industry: Biotechnology
| Company | Market Cap (USD) |
|---|---|
| Novo Nordisk | $622.07 B |
| Vertex Pharmaceuticals Incorporated | $121.36 B |
| Regeneron Pharmaceuticals, Inc. | $115.11 B |
| CSL Limited | $95.75 B |
| Marinomed Biotech AG | $75.67 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $808.65 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $450.89 B |
| Johnson & Johnson | $350.63 B |
| Merck | $318.75 B |
Detailed Description
Modus Therapeutics Holding Ab, a biotechnology company, develops a treatment for sepsis and septic shock in Sweden. It is developing Sevuparin, a polysaccharide to treat patients with sepsis and septic shock. The company was founded in 2011 and is headquartered in Stockholm, Sweden.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Stocks & Indices
Modus Therapeutics Holding AB has the following listings and related stock indices.
Stock: OMX: MODTX wb_incandescent